Terry Keith Blue, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1108 E Waterview Dr, Andover, KS 67002 Phone: 316-425-8153 Fax: 316-425-8153 |
Jeff Andrew Carpenter, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-300-4000 |
Ms. Sharon L Barocco, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2117 S Andover Rd, Andover, KS 67002 Phone: 316-733-8166 |
John Phillip Weller, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-300-4000 |
Caitlin Carpenter, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-440-3200 |
Mrs. Pegah Vahdat Harlan, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 945 W Threewood Ct, Andover, KS 67002 Phone: 515-339-6994 |
Ryan Kaub, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1124 W 21st St, Andover, KS 67002 Phone: 316-300-4000 |
News Archive
Imagine a chip, strategically placed in the brain, that could prevent epileptic seizures or allow someone who has lost a limb to control an artificial arm just by thinking about it.
GenSpera, Inc. (OTCQB:GNSZ) announced that the first patient was enrolled in the Phase II clinical trial of its lead compound, G-202, in patients who have glioblastoma multiforme (GBM), the most prevalent type of primary brain cancer.
In an Early Edition issue of The Proceedings of the National Academy of Sciences (PNAS) on April 9, 2009, the researchers report that they have been able to determine the molecular structure of a plant photolyase protein that is surprisingly similar to two cryptochrome proteins that control the "master clock" in humans and other mammals.
Daiichi Sankyo Company, Limited, announced today that the company has received its first marketing approval for LIXIANA 15 mg and 30 mg tablets, by the Ministry of Health, Labor and Welfare in Japan.
For children with obstructive sleep apnea, standard care often includes a tonsillectomy and adenoidectomy. But researchers at Saint Louis University say further research is needed to determine if surgery is the best option for these patients.
› Verified 7 days ago